Mass General Brigham to Invest $100 Million in Telehealth and Digital Tools.
The five-year project aims to support consumer-centered care and patient engagement technology use.
PatientEngagementHIT.com
"Project...
Dyve Biosciences (Private) Receives FDA Clearance to Begin Phase 2 Study of DYV-700 for...
THOUSAND OAKS, Ca.--(BUSINESS WIRE)--Dyve Biosciences, Inc. today announced that it has received clearance from the U.S. Food and Drug Administration to proceed...
“I Dare the FDA not to Approve Our Drug.”
"Woe, Woe, Woe Wait a Minute. We Meant That Biogen Respects and Appreciates the FDA Review Process.” All Hail the FDA! Biogen...
True Nature (TNTY), a Medtech Startup Incubator Pays Down Some Toxic Notes.
This is a Welcome Step in the Right Direction.
ATLANTA, GA, Nov. 29, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE...
Frontier Bio (FBIO) Bolstering it’s Warchest.
Fortress Biotech Announces Pricing of Series A Preferred Stock Offering
Is True Nature (TNTY) $0.04, Nearing a Breakout?
After a Tough Year, a Series of Development Releases Appears to Have Halted True Natures Downtrend and Move to a Possible...
True Nature’s (TNTY) CEO Larry Diamond on Wall Street Analyzer.
Larry Diamond Reveals Some of True Nature's Goals and Ambitions to Incubate Medical Related Startups to Benefit All Shareholders.
AR Threats Report (CDC)
This report is dedicated to the 48,700 familieswho lose a loved one each year to antibiotic resistanceor Clostridioides difficile, and the...
Biotech’s Turning Up…
Biotech Sector Gains Near 10% in Past Month, After Biogen (BIIB) Reports Breaking News.
We keep telling investors...
True Nature | Mitesco (TNTY), Perking Up.
Is it too early to nick-name True Nature's Medtech incubator Mitesco the "Mighty Mitesco?" Of course it's too early - but it...